Novo Nordisk shares plunge 19% after disappointing trial results; Lilly jumps in premarket
Shares of Novo Nordisk dropped over 24% after disappointing results in a trial for its CagriSema weight loss drug, which ...
Shares of Novo Nordisk dropped over 24% after disappointing results in a trial for its CagriSema weight loss drug, which ...
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.